Solving antimicrobial resistance
Viotika Life Sciences Inc. is a Canadian biotech company advancing novel research in pursuit of a solution to the escalating global crisis of antimicrobial resistance (AMR).
Left unchecked, some experts say, AMR will be responsible for up to 10,000,000 deaths a year by 2050, as today’s conventional antibiotics become increasingly ineffective in treating infection.
It has been over 30 years since a new class of antibiotics has been successfully introduced to the market. Viotika’s platform represents a new class, a new approach, and new hope.
Solving antimicrobial resistance
Viotika Life Sciences Inc. is a Canadian biotech company advancing novel research in pursuit of a solution to the escalating global crisis of antimicrobial resistance (AMR).
Left unchecked, AMR will be responsible for up to 10,000,000 deaths a year by 2050, as today’s conventional antibiotics become increasingly ineffective in treating infection.
It has been over 30 years since a new class of antibiotics has been successfully introduced to the market. Viotika’s platform represents a new class, a new approach, and new hope.
We are on our way to becoming the world’s first Indigenous-majority-owned biotech company dedicated to solving antimicrobial resistance (AMR).
